Skip to main content

Another Downer For Merck’s Cholesterol Drugs

Quoted: James Stein, an artery imaging expert at the University of Wisconsin-Madison. In other words, HALTS has gone from a study where a muted result seemed likely to one where a clear and definitive outcome seems assured.